Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular basis for complement component 6 (C6) deficiency in rats and mice.

Deepak Bhole1, Gregory L Stahl

  • 1Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham & Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

Immunobiology
|December 1, 2004
PubMed
Summary

Researchers identified the genetic causes of complement component C6 deficiency in rats and mice. C6 deficiency was linked to a deletion in rats and mutations in mice, unexpectedly revealing a coagulation defect in deficient animals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibodies to mannose-binding lectin and factor XI Inhibit Shiga toxin-induced kidney injury additively in a murine model.

Pediatric research·2026
Same author

Dietary sugars inhibit biologic functions of the pattern recognition molecule, mannose-binding lectin.

Open journal of immunology·2026
Same author

Mannose-binding lectin (MBL) and the lectin complement pathway play a role in cutaneous ischemia and reperfusion injury.

Innovative surgical sciences·2021
Same author

Both platelets and fibrin deposition are increased in the glomeruli of mice after treatment with Shiga toxin-2.

Kidney international·2017
Same author

Complementary Roles of the Classical and Lectin Complement Pathways in the Defense against <i>Aspergillus fumigatus</i>.

Frontiers in immunology·2016
Same author

Human mannose-binding lectin inhibitor prevents Shiga toxin-induced renal injury.

Kidney international·2016

Area of Science:

  • Immunology
  • Genetics
  • Hematology

Background:

  • Complement component C6 (C6) is crucial for the lytic membrane attack complex in complement activation.
  • Rodent models deficient in C6 are used to study complement's role in human disease, but the genetic basis of these deficiencies is unknown.
  • Understanding C6 deficiency is vital for accurate animal modeling in immunological and disease research.

Purpose of the Study:

  • To elucidate the molecular basis of C6 deficiency in rat and mouse strains.
  • To develop genetic tests for identifying C6-deficient rodents.
  • To investigate potential secondary effects of C6 deficiency, such as coagulation abnormalities.

Main Methods:

  • Isolation and sequencing of rat C6 mRNA using EST-derived oligonucleotides.

Related Experiment Videos

  • Identification of gene mutations (deletion in rats, point mutations in mice) responsible for C6 deficiency.
  • Development of a PCR-based genotyping assay for rat C6 deficiency.
  • Assessment of tail bleeding times and platelet aggregation in C6-deficient and wild-type rodents.
  • Main Results:

    • A 31 bp deletion in exon 10 of the C6 gene was identified as the cause of deficiency in PVG rats (PVG/c-).
    • Four point mutations in the mouse C6 gene were found, potentially explaining C6 deficiency in the Peru-Coppock strain.
    • C6-deficient mice and rats exhibited prolonged bleeding times and reduced platelet aggregation, indicating a coagulation defect.
    • Treatment with purified rat C6 protein reversed the prolonged bleeding times in deficient animals.

    Conclusions:

    • The genetic underpinnings of C6 deficiency in specific rat and mouse strains have been identified.
    • A reliable PCR-based genotyping method for rat C6 deficiency has been established.
    • Complement component C6 deficiency is unexpectedly associated with a coagulation defect, the mechanism of which requires further investigation.